Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723786 | SCV000203573 | uncertain significance | not provided | 2014-02-06 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000153955 | SCV000597068 | likely benign | not specified | 2016-03-28 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001080009 | SCV000754306 | benign | Spastic paraplegia | 2024-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316973 | SCV000851967 | benign | Inborn genetic diseases | 2017-11-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000723786 | SCV001844872 | benign | not provided | 2019-07-09 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847786 | SCV002105201 | likely benign | Hereditary spastic paraplegia | 2017-01-31 | criteria provided, single submitter | clinical testing |